<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00864188</url>
  </required_header>
  <id_info>
    <org_study_id>08.29.NRC</org_study_id>
    <nct_id>NCT00864188</nct_id>
  </id_info>
  <brief_title>The Influence of Probiotics in a Drinkable Yogurt on Skin Health</brief_title>
  <official_title>Phase 1 The Influence of Probiotics in a Drinkable Yogurt on Skin Health</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nestlé</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nestlé</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to test if probiotics administered to healthy female subjects in a&#xD;
      dairy format have any skin health benefits.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a placebo-controlled, double blind, randomized, single center, human clinical trial&#xD;
      aimed at assessing the influence of probiotics on skin health in healthy female subjects,&#xD;
      when administered in a food matrix over a period of 5 months.&#xD;
&#xD;
      It will consist of five groups(40 subjects/group). The first group (1) of subjects will&#xD;
      receive acidified milk that does not contain bacterial strains. The second group (2) will&#xD;
      receive acidified milk that contains one specific probiotic strain. The third group (3) will&#xD;
      receive fermented milk that contains a standard mix of yogurt bacterial strains. The fourth&#xD;
      group (4) will receive fermented milk, containing the same standard mix of yogurt bacterial&#xD;
      strains as in group 3 plus the same specific probiotic strain as in group 2. Finally, the&#xD;
      fifth group (5) will receive fermented milk, containing the same standard mix of yogurt&#xD;
      bacterial strains as in group 3 and 4 plus the same specific probiotic strain as in group 2&#xD;
      and 4 plus a mix of antioxidants.&#xD;
&#xD;
      This study will address whether:&#xD;
&#xD;
      A.The bioefficacy of a specific probiotic strain is influenced by a milk matrix.&#xD;
&#xD;
      B.Whether other bacterial strains impact the bioefficacy of this specific probiotic strain,&#xD;
      and validate whether or not the bioefficacy is related entirely to the activity of this&#xD;
      specific probiotic strain.&#xD;
&#xD;
      C.Whether nutritional supplements impact the bioefficacy of a specific probiotic strain.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2009</start_date>
  <completion_date type="Actual">April 2010</completion_date>
  <primary_completion_date type="Actual">April 2010</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Transepidermal water loss</measure>
    <time_frame>baseline, 1 month, 2 months, 3 months, 5 months and 6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Biopsy markers: transglutaminase, filagrin, involucrin, loricrin (mRNA)</measure>
    <time_frame>baseline and at 5 months</time_frame>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">207</enrollment>
  <condition>Skin Health</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Glucono-Delta-Lactone acidified milk containing no bacterial strains</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Glucono-Delta-Lactone acidified milk containing one probiotic strain called Lactobacillus paracasei NCC2461.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Fermented milk containing two standard bacterial strains for acidification - Streptococcus thermophilus and Lactobacillus delbrueckii subsp.bulgaricus.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fermented milk containing two standard bacterial strains for acidification - Streptococcus thermophilus and Lactobacillus delbrueckii and one probiotic strain called Lactobacillus paracasei NCC2461.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fermented milk containing two standard bacterial strains for acidification - Streptococcus thermophilus and Lactobacillus delbrueckii, one probiotic strain called Lactobacillus paracasei NCC2461 and Vitamin B2,B3, C and E, Beta Carotene and an Oil.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>no bacterial strains</intervention_name>
    <description>Glucono-Delta-Lactone acidified milk containing no bacterial strains</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>One probiotic strain - Lactobacillus paracasei NCC2461</intervention_name>
    <description>Glucono-Delta-Lactone acidified or fermented milk containing one probiotic strain.</description>
    <arm_group_label>2</arm_group_label>
    <arm_group_label>4</arm_group_label>
    <arm_group_label>5</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Two standard yogurt fermenting bacterial strains - Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus</intervention_name>
    <description>Fermented milk containing two standard yogurt bacterial strains.</description>
    <arm_group_label>3</arm_group_label>
    <arm_group_label>4</arm_group_label>
    <arm_group_label>5</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vit B2, B3, C and E, Beta Carotene and Oil</intervention_name>
    <description>Fermented milk containing nutritional supplements</description>
    <arm_group_label>5</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy women as assessed by medical history and standard medical examination&#xD;
&#xD;
          -  Caucasian&#xD;
&#xD;
          -  Age: 25-55 y (inclusive)&#xD;
&#xD;
          -  Normal BMI ≤ 30&#xD;
&#xD;
          -  Skin type 1-111&#xD;
&#xD;
          -  Regular Hormonal Cycle&#xD;
&#xD;
          -  Having given his/her written informed consent&#xD;
&#xD;
          -  Willing to avoid the consumption of fermented dairy products&#xD;
&#xD;
          -  Minimum consumption of dark chocolate during the period of the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Smoker&#xD;
&#xD;
          -  Pregnant or lactating women&#xD;
&#xD;
          -  Post menopausal women&#xD;
&#xD;
          -  Heavy alcohol intake (usually consuming more than 3 standard drinks/day)&#xD;
&#xD;
          -  Intake of chronic medications except oral contraceptive&#xD;
&#xD;
          -  Vitamin and/or mineral and/or antioxidant supplementation over the 3 months preceding&#xD;
             the initiation of the study and throughout the study.&#xD;
&#xD;
          -  Having skin cancer or genetic disposition to skin cancer&#xD;
&#xD;
          -  Regular exposure to artificial UVR&#xD;
&#xD;
          -  Daily exposure to sun more than one week over the 2 months preceding the initiation of&#xD;
             the study&#xD;
&#xD;
          -  Planned vacation to sun during the period of the study.&#xD;
&#xD;
          -  Excessive tea drinkers (more than 2 cups a day of green or black tea).&#xD;
&#xD;
          -  Excessive consumer of fermented dairy products (more than 150g per day).&#xD;
&#xD;
          -  Excessive consumer of dark chocolate (&gt; 25g per day).&#xD;
&#xD;
          -  Regular high exercise such as a marathon&#xD;
&#xD;
          -  Subject who regularly takes saunas (dry or wet) or swims daily.&#xD;
&#xD;
          -  Subject who cannot be expected to comply with treatment&#xD;
&#xD;
          -  Currently participating or having participated in another interventional clinical&#xD;
             trial during the last 3 months prior to the beginning of this study.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Institut für umweltmedizinische Forschung (IUF) an der Heinrich-Heine-Universität Düsseldorf gGmbH</name>
      <address>
        <city>Düsseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2009</verification_date>
  <study_first_submitted>March 13, 2009</study_first_submitted>
  <study_first_submitted_qc>March 17, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 18, 2009</study_first_posted>
  <last_update_submitted>May 15, 2013</last_update_submitted>
  <last_update_submitted_qc>May 15, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 16, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>skin health</keyword>
  <keyword>probiotics</keyword>
  <keyword>dairy</keyword>
  <keyword>oral</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Beta Carotene</mesh_term>
    <mesh_term>Carotenoids</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

